Side effects of taking Mounjaro: what happens, when, and what to do

Step 1, the first few weeks: settling your system

Most people notice something in the first week. Nausea is the most common report; it often arrives in the hours after the injection and tends to be mild to moderate rather than incapacitating. Loose stools or, for some, constipation can appear at the same time. Burping, indigestion and a general slowing of appetite are also typical, the last of those is, of course, part of how tirzepatide works.

Fatigue and mild headaches are less talked about but appear in the trial data. Injection-site redness or itching occurs for some; rotating between the abdomen, thigh and upper arm each week reduces localised irritation.

A question our prescribers hear most weeks is whether the nausea means the medicine is harming you. In the vast majority of cases, it reflects the medicine doing exactly what it is designed to do (slowing gastric emptying) rather than anything going wrong. Small, low-fat meals, staying well hydrated and avoiding lying down shortly after eating all help. The timing of when these effects typically hit varies slightly person to person, but most people find the worst of it passes before the four-week mark at any given dose.

If nausea is severe or you cannot keep fluids down, contact your prescriber or GP rather than waiting it out. Dehydration from persistent vomiting or diarrhoea can affect kidney function.

Step 2, dose increases: when side effects can return

Tirzepatide is titrated upward roughly every four weeks, from 2.5 mg through to whatever maintenance dose your prescriber decides is appropriate. Each step up can bring a brief recurrence of the GI effects you experienced at the start. This is predictable and temporary, not a sign that the higher dose is wrong for you.

For women using oral contraceptives, the MHRA advises adding a non-oral method of contraception for the first four weeks of treatment and for four weeks after each dose increase, because tirzepatide's effect on gastric emptying may reduce how much of the pill is absorbed. Transdermal contraception (patches or implants) is not affected in the same way. NHS England's guidance on weight-management injections covers this clearly.

Diarrhoea specifically can be more pronounced at higher doses for some people. Managing diarrhoea on Mounjaro involves similar principles to the early weeks, hydration, avoiding high-fat foods, and giving the dose time to settle. If it persists beyond two weeks at a new dose level, your prescriber needs to know.

The side-effect picture at each dose level is broadly similar; the intensity tends to reduce over the course of the titration schedule as your body adjusts. Many people find that by the time they reach a higher dose, they barely notice the GI effects that troubled them at 2.5 mg.

Step 3 (ongoing treatment: less common but more serious effects to know

Across the full side-effect profile) if you want a thorough overview, our page covering what are the side effects of taking Mounjaro goes into each reaction in detail, and most reactions are mild and transitory. The less common ones deserve attention precisely because they are easy to miss or attribute to something else.

Gallbladder problems, including gallstones and cholecystitis, have been reported with GLP-1 and dual-agonist medicines. Symptoms include persistent pain in the upper right abdomen, sometimes spreading to the shoulder. Tell your GP if this develops.

Hair thinning (telogen effluvium) is reported by some people on weight-loss treatment generally. It tends to relate to rapid calorie reduction rather than the medicine itself and typically resolves. Raise it with your prescriber if it concerns you.

Mood changes are less clearly established as a direct effect, but they are worth monitoring. If you notice low mood or any self-harm thoughts, contact your prescriber or GP promptly. The broader safety picture for Mounjaro sets out what the current evidence says on this.

For people with type 2 diabetes taking insulin or sulphonylureas alongside Mounjaro, low blood sugar (hypoglycaemia) is an added consideration. Your prescriber should review your diabetes medicines when starting tirzepatide.

When to get medical help without delay

Some symptoms need urgent attention rather than watchful waiting. Severe, persistent stomach pain that radiates through to your back (with or without vomiting) is a warning sign of acute pancreatitis, which the MHRA highlighted in its January 2026 Drug Safety Update for GLP-1 medicines as an infrequent but serious risk. Call 111 or go to A&E.

Other red flags: signs of a serious allergic reaction (rash, swelling of the face or throat, difficulty breathing); sudden or worsening vision changes; symptoms of gallbladder disease as described above; severe dehydration from persistent GI illness, and, for anyone who has cardiovascular risk factors, it is also worth reading about Mounjaro stroke risk so you know which neurological warning signs to act on promptly. None of these are common. Knowing them matters anyway.

Side effects worth reporting but not classed as emergencies (injection-site lumps, persistent nausea at a given dose, mood changes) should go to your prescriber at the next contact, and our dedicated page on the side effects of taking tirzepatide is a useful reference if you want to check whether what you are experiencing is recognised before your next call. At nume, aftercare support is available seven days a week, so you do not have to wait for a scheduled review if something is worrying you. Suspected side effects can also be logged directly with the MHRA via Yellow Card, you do not need a clinician to do this for you.